Title : Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Pub. Date : 2001 Nov

PMID : 11606667






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: At 3 months, galantamine (24-32 mg/day) produced a significantly better outcome on cognitive function than placebo (treatment difference=1.9 points on ADAS-cog, p=0.002) and a significantly better global response than placebo, as measured by CIBIC-plus (deterioration in 21% of patients on galantamine v 37% on placebo; p<0.001). Galantamine alkylglycerone phosphate synthase Homo sapiens